A total of 30 patients with ischemic cardiomyopathy and the median left venticular ejection fraction ( LVEF ) of 35.9 4.7 % were prospectively and randomly enrolled in a single center interventional , open labeled clinical trial as two groups : group I of 15 patients designated as the study group to receive CABG surgery and intramyocardial implantation of BMMNC and group II of 15 patients as the control group to receive only the CABG procedure .